Pharmaceutical Business Review
Return to: PBR Home | Companies

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc
2855 Gazelle Court
United States of America
Phone: 1 760 9319200
Fax: 13-02-6555049

No. employees: 547
Turnover: 507.67 (US$m)
Financial year end: December

Company Overview

Top Competitors

Key Employees

Joseph Klein, III

Director, Executive Board

Stanley T. Crooke, M.D., Ph.D.

Chief Executive Officer, Chairman, Executive Board

Frederick T. Muto

Director, Non Executive Board

Spencer R. Berthelsen, M.D.

Director, Non Executive Board

Joseph H. Wender

Director, Non Executive Board

Joseph Loscalzo, M.D., Ph.D.

Director, Non Executive Board

Breaux Castleman

Director, Non Executive Board

B. Lynne Parshall

Director, Non Executive Board

C. Frank Bennett, Ph.D.

Senior Vice President - Antisense Research, Senior Management

Brett P. Monia, Ph.D.

Senior Vice President - Drug Discovery and Corporate Development, Chief Operating Officer, Senior Management

Elizabeth L. Hougen

Senior Vice President - Finance, Chief Financial Officer, Senior Management

Patrick R. O’Neil

Senior Vice President - Legal , General Counsel, Chief Compliance Officer, Secretary, Senior Management

Richard S. Geary, Ph.D.

Senior Vice President - Development, Senior Management

Sarah Boyce

Chief Business Officer, Senior Management

Sanjay Bhanot

Chief Medical Officer, Senior Management

Steve Hughes

Chief Clinical Development Officer, Senior Management


2855 Gazelle Court,
United States of America
Phone: 1 760 9319200
Fax: 1 302 6555049

Akcea Therapeutics UK Limited

Office 32 19-21 Crawford Street,
United Kingdom

Akcea Therapeutics Inc

55 Cambridge Pkwy Ste 100,
United States of America
Phone: 1 760 6032732
Fax: 1 302 6555049

Isis USA Limited

United States of America

PerIsis I Development Corporation

2292 Faraday Ave,
United States of America

Regulus Therapeutics Inc

10614 Science Center Drive,
San Diego,
United States of America
Phone: 1 858 2026300

Symphony GenIsis Inc

7361 Calhoun Place,
Suite 325,
United States of America



  • Product Pipeline:
  • Cardiovascular:
  • ISIS-CRP-Coronary Artery Disease
  • ISIS-FXI-Clotting Disorders
  • ISIS-APOCIII-High Triglycerides
  • BMS-PCSK9-Cardiovascular Disease
  • Metabolic Disease:
  • ISIS-GCGR-Diabetes
  • ISIS-GCCR-Diabetes
  • ISIS 113715-Diabetes
  • ISIS-SGLT2-Diabetes
  • Cancer:
  • OGX-011-Prostate, Lung, and Breast Cancer
  • ISIS-EIF4E-Cancer
  • OGX-427-Cancer
  • LY2181308-Prostate Cancer
  • Neurodegenerative Diseases:
  • ISIS-SMN-Spinal Muscular Atrophy
  • ISIS-SOD1-Amyotrophic Lateral Sclerosis
  • Inflammatory Disease:
  • Alicaforsen-Ulcerative Colitis, Pouchitis
  • ATL1102-Multiple Sclerosis
  • AIR645-Asthma
  • Other:
  • Vitravene-CMV Retinitis
  • iCo-007-Diabetic Macular Edema, Diabetic Retinopathy
  • ACHN-490-Severe Bacterial Infection
  • ATL1103-Acromegaly, Diabetic Retinopathy
  • EXC 001-Local Fibrosis